İLKO İlaç and Wellcare Prepare for 2026 with "Leave a Mark" Vision

İLKO İlaç and consumer health brand Wellcare, representing over 50 years of accumulated expertise and experience, gathered at their Year-End Meeting themed "Leave a Mark" to review 2025 and set targets for 2026.

Standing out in the sector through their forward-looking initiatives and R&D investments, all field and management teams of İLKO İlaç and the Wellcare family convened at the Year-End Meeting held in Cyprus to review 2025 and determine 2026 strategies. The İLKO İlaç and Wellcare family, shaped by the theme "Leave a Mark," once again demonstrated their firm commitment to building a future in 2026 where they will produce together, grow stronger together, and stand out in the sector through sustainable success.

A strong vision to leave its mark on 2026
Selçuklu Holding and İLKO İlaç Board Chairman İsmail Öncel delivered a comprehensive assessment of 2025 during his remarks at the meeting, sharing strategic priorities that will shape 2026. In his address, İsmail Öncel stated: "2026 will be a year not just of discussing targets, but of executing decisions without compromise, with responsibility and productivity at the forefront. As İLKO İlaç and Wellcare, we are advancing on the path to becoming an organization that leads change courageously rather than merely following it, leaving lasting marks," expressing his confidence in his teams.

At the meeting held at Limak Cyprus Deluxe Hotel on 14-18 January, İLKO İlaç General Manager Hatice Öncel shared her assessment of 2025 and her outlook for 2026. Emphasizing that the new year will be a strategic turning point for the company, Hatice Öncel stated: "2026 will be the beginning of a period in which İLKO İlaç and Wellcare will leave lasting marks in the sector. With our strengthened organizational structure and the contributions of our teams, we will resolutely realize our long-term vision encompassing not only today but also 2027 and beyond."

Growth performance and strategic targets
İLKO İlaç Board Member Mustafa Cem Öncel shared 2025 performance results and next-period targets. Öncel reported that İLKO İlaç achieved 45% growth in net sales and 11% growth in unit sales in the combined Rx and OTC groups in the domestic market. He emphasized that Wellcare, performing 15 points above the general 57% growth of the OTC market, achieved 72% growth in net sales and 23% growth in unit sales.

The meetings continued with a presentation by İLKO İlaç Sales and Marketing Director Taner Gülfırat, emphasizing that great achievements will be accomplished as a result of tireless determination, constantly demanding the best, and working with passion. Wellcare Business Unit Director İlhan Ok concluded his remarks sharing Wellcare's success momentum from the past year with the advertisement film "You'll Love Living with Wellcare," prepared as part of the new communication campaign.

Success achievements crowned with awards
At the opening of this large gathering where all field and head office staff came together, Report Card Awards were presented to Medical Representatives, Regional Managers, and Regional Sales Managers who placed in the top three throughout the year with their performance. Following the Report Card Awards, Seniority Awards were presented to employees who completed their 5th, 10th, and 15th years of service within İLKO İlaç. While 5-year seniority plaques were presented by Sales and Marketing Director Taner Gülfırat, employees completing their 10th year received their plaques from Board Members Mustafa Cem Öncel and Alperen Öncel. The 15-year seniority plaque was presented by General Manager Hatice Öncel.

Strategic vision reinforced through product launches
At the meeting concluded with a magnificent gala night, 5 new Rx products supporting İLKO İlaç's sustainable growth strategy and reflecting its scientific strength and R&D focus were launched, along with Ceramide Complex, Iodine Selenium, and Bromelain Trio products developed under the Wellcare umbrella. The meeting was supported with training programs and assessment sessions, strengthening the knowledge and motivation of the teams.